{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:13Z","timestamp":1786120273739,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/mnm.0b013e328349eafc","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T14:08:28Z","timestamp":1317737308000},"page":"1084-1087","source":"Crossref","is-referenced-by-count":4,"title":["Selective approach to radionuclide-guided sentinel lymph node biopsy in high-risk ductal carcinoma in situ of the breast"],"prefix":"10.1097","volume":"32","author":[{"given":"Sharjeel","family":"Usmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha Al","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawaz abu","family":"Huda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Marafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henney G.","family":"Amanguno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naheel Al","family":"Nafisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farida Al","family":"Kandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210212","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/jnci\/94.20.1546","article-title":"Detection of ductal carcinoma in situ in women undergoing screening mammography.","volume":"94","author":"Ersnter","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R2-16-20210212","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMra031301","article-title":"Ductal carcinoma in situ of the breast.","volume":"350","author":"Burstein","year":"2004","journal-title":"N Engl J Med"},{"key":"R3-16-20210212","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/jnci\/djh069","article-title":"Trends in the treatment of ductal carcinoma in situ of the breast.","volume":"96","author":"Baxter","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R4-16-20210212","first-page":"211","article-title":"Axillary lymphadenectomy for intraductal carcinoma of the breast.","volume":"172","author":"Silverstein","year":"1991","journal-title":"Surg Gynaecol Obst"},{"key":"R5-16-20210212","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1245\/s10434-007-9414-8","article-title":"Outcomes for women with ductal carcinoma-in situ and a positive sentinel node: a multi-institutional audit.","volume":"14","author":"Moore","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R6-16-20210212","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jamcollsurg.2004.11.012","article-title":"Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.","volume":"200","author":"Yen","year":"2005","journal-title":"J Am Coll Surg"},{"key":"R7-16-20210212","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1075-122X.2006.00292.x","article-title":"Consensus conference on breast conservation, Milan, Italy, 28 April-1 May 2005.","volume":"12","author":"Schwartz","year":"2006","journal-title":"Breast J"},{"key":"R8-16-20210212","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.","volume":"23","author":"Lyman","year":"2005","journal-title":"J Clin Oncol"},{"key":"R9-16-20210212","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00259-003-1390-z","article-title":"Optimised nuclear medicine method for tumor marking and sentinel node detection in occult primary breast lesions.","volume":"31","author":"De Cicco","year":"2004","journal-title":"Eur J Med Mol Imaging"},{"key":"R11-16-20210212","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10434-000-0015-z","article-title":"Sentinel node biopsy in ductal carcinoma in situ patients.","volume":"7","author":"Pendas","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"R12-16-20210212","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"Randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.","volume":"349","author":"Veronesi","year":"2003","journal-title":"N Engl J Med"},{"key":"R13-16-20210212","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1200\/JCO.2006.08.4228","article-title":"Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.","volume":"25","author":"Rodier","year":"2007","journal-title":"J Clin Oncol"},{"key":"R14-16-20210212","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00259-005-1801-4","article-title":"Sentinel node biopsy and selective lymph node clearance impact on regional control and survival in breast cancer and melanoma.","volume":"32","author":"Nieweg","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R15-16-20210212","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/SLA.0b013e31812e6a73","article-title":"A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the SentinellaGIVOM trial.","volume":"247","author":"Zavagno","year":"2008","journal-title":"Ann Surg"},{"key":"R16-16-20210212","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/modpathol.3880497","article-title":"Histologic and radiographic analysis of ductal carcinoma in situ diagnosed using stereotactic incisional core breast biopsy.","volume":"15","author":"Bonnett","year":"2002","journal-title":"Mod Pathol"},{"key":"R17-16-20210212","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y","article-title":"Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.","volume":"86","author":"Fisher","year":"1999","journal-title":"Cancer"},{"key":"R18-16-20210212","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/j.semnuclmed.2004.11.003","article-title":"Update on detection of sentinel lymph nodes in patients with breast cancer.","volume":"35","author":"Aarsvold","year":"2005","journal-title":"Semin Nucl Med"},{"key":"R19-16-20210212","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/archsurg.137.11.1249","article-title":"Risk factors for lymph node metastases in breast carcinoma in situ with minimal invasive component.","volume":"137","author":"Wasserberg","year":"2002","journal-title":"Arch Surg"},{"key":"R20-16-20210212","first-page":"29","article-title":"In-situ breast carcinoma.","volume":"26","author":"Frykberg","year":"1993","journal-title":"Adv Surg"},{"key":"R22-16-20210212","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ciresp.2008.09.002","article-title":"Benefit of sentinel node biopsy in patients with breast ductal carcinoma in situ.","volume":"85","author":"Rubio","year":"2009","journal-title":"Cir Esp"},{"key":"R23-16-20210212","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/bjs.6162","article-title":"Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast.","volume":"95","author":"Ansari","year":"2008","journal-title":"Br J Surg"},{"key":"R25-16-20210212","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archsurg.138.5.537","article-title":"Casting-type calcifications with invasion and high-grade ductal carcinoma in situ.","volume":"138","author":"Zunzunegui","year":"2003","journal-title":"A more aggressive disease Arch Surg"},{"key":"R27-16-20210212","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejso.2008.07.007","article-title":"The role of sentinel node biopsy in ductal carcinoma in situ of the breast.","volume":"35","author":"Polom","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"R28-16-20210212","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archsurg.138.3.309","article-title":"Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast.","volume":"138","author":"Intra","year":"2003","journal-title":"Arch Surg"},{"key":"R29-16-20210212","first-page":"466","article-title":"Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy.","volume":"217","author":"Lee","year":"2000","journal-title":"Can invasion be predicted Radiology"},{"key":"R30-16-20210212","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1524-4741.2007.00543.x","article-title":"Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.","volume":"14","author":"Tunon-de-Lara","year":"2008","journal-title":"Breast J"},{"key":"R31-16-20210212","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10434-001-0275-2","article-title":"Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction.","volume":"8","author":"Lagios","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"R32-16-20210212","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.","volume":"23","author":"Lyman","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006231-201111000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:25:24Z","timestamp":1786047924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006231-201111000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e328349eafc","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}